Indonesia to produce mRNA Covid-19 vaccines for Southeast Asia

Indonesia’s Bio Farma already produces Covid-19 vaccines based on China’s Sinovac and will now start with mRNA doses

Indonesia is set to start producing its own mRNA-based Covid-19 vaccines after the World Health Organisation (WHO) appointed the country as one of the beneficiaries of mRNA-based vaccine technology transfer from established pharmaceutical companies.

This is widely seen as a signal of the WHO’s confidence in Indonesia to become a hub for Covid-19 vaccine production in the Southeast Asia region, the Jakarta Globe cited the country’s minister of state-owned enterprises Erick Thohir as saying on February 25.

State company PT Bio Farma will start producing mRNA doses, according to the minister, who did not name the brand. The company is one of the largest vaccine manufacturers in the region, with the capacity to produce 3.2 billion doses a year.

Indonesia has sought global support for years to make its own Covid-19 vaccines in order to inoculate its population, the fourth-largest in the world, and ship vaccines to neighbouring countries. A lack of supply has led it to give out half-doses for its booster program to ensure it has enough for all 270 million of its people.

“Solution for developing countries”

The self-production of mRNA vaccines “is the kind of solution that developing countries need, a solution that empowers, a solution that strengthens our self-reliance, a solution that allows us to contribute to global health resilience,” Indonesian foreign minister Retno Marsudi said on Twitter.

The WHO is planning to set up tech transfer hubs across developing countries to help them produce mRNA vaccines.

Its director-general Tedros Adhanom Ghebreyesus said the organisation would share the technology with Bangladesh, Pakistan, Serbia and Vietnam to ramp up the manufacturing and supplies of the vaccine to low and middle-income countries. In South Africa, scientists backed by the WHO already made a Covid-19 vaccine candidate that matches the one by Moderna.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

 

 

[caption id="attachment_38259" align="alignleft" width="300"] Indonesia's Bio Farma already produces Covid-19 vaccines based on China's Sinovac and will now start with mRNA doses[/caption] Indonesia is set to start producing its own mRNA-based Covid-19 vaccines after the World Health Organisation (WHO) appointed the country as one of the beneficiaries of mRNA-based vaccine technology transfer from established pharmaceutical companies. This is widely seen as a signal of the WHO’s confidence in Indonesia to become a hub for Covid-19 vaccine production in the Southeast Asia region, the Jakarta Globe cited the country’s minister of state-owned enterprises Erick Thohir as saying on February 25. State...

Indonesia’s Bio Farma already produces Covid-19 vaccines based on China’s Sinovac and will now start with mRNA doses

Indonesia is set to start producing its own mRNA-based Covid-19 vaccines after the World Health Organisation (WHO) appointed the country as one of the beneficiaries of mRNA-based vaccine technology transfer from established pharmaceutical companies.

This is widely seen as a signal of the WHO’s confidence in Indonesia to become a hub for Covid-19 vaccine production in the Southeast Asia region, the Jakarta Globe cited the country’s minister of state-owned enterprises Erick Thohir as saying on February 25.

State company PT Bio Farma will start producing mRNA doses, according to the minister, who did not name the brand. The company is one of the largest vaccine manufacturers in the region, with the capacity to produce 3.2 billion doses a year.

Indonesia has sought global support for years to make its own Covid-19 vaccines in order to inoculate its population, the fourth-largest in the world, and ship vaccines to neighbouring countries. A lack of supply has led it to give out half-doses for its booster program to ensure it has enough for all 270 million of its people.

“Solution for developing countries”

The self-production of mRNA vaccines “is the kind of solution that developing countries need, a solution that empowers, a solution that strengthens our self-reliance, a solution that allows us to contribute to global health resilience,” Indonesian foreign minister Retno Marsudi said on Twitter.

The WHO is planning to set up tech transfer hubs across developing countries to help them produce mRNA vaccines.

Its director-general Tedros Adhanom Ghebreyesus said the organisation would share the technology with Bangladesh, Pakistan, Serbia and Vietnam to ramp up the manufacturing and supplies of the vaccine to low and middle-income countries. In South Africa, scientists backed by the WHO already made a Covid-19 vaccine candidate that matches the one by Moderna.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

 

 

NO COMMENTS

Leave a Reply